Lipooligosaccharide structures of invasive and carrier isolates of Neisseria meningitidis are correlated with pathogenicity and carriage

Journal of Biological Chemistry

Volumn 291, Issue 7, 2016, Pages 3224-3238

  John, Constance M ^a,b   Phillips, Nancy J ^b   Din, Richard ^a   Liu, Mingfeng ^a,b   Rosenqvist, Einar ^c   Høiby, E Arne ^c   Stein, Daniel C ^d   Jarvis, Gary A ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d University of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; CARBOXYLIC ACIDS; CELL MEMBRANES; DESORPTION; GENES; OLIGOSACCHARIDES; PHOSPHORYLATION;

BIOSYNTHETIC GENE; GENOMIC ANALYSIS; IMMUNE TOLERANCES; INNATE IMMUNE RESPONSE; LIPOOLIGOSACCHARIDES; NEISSERIA MENINGITIDIS; PHOSPHOETHANOLAMINE; PHOSPHORYLATED LIPIDS;

MASS SPECTROMETRY;

LIPID A; LIPOOLIGOSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL ANTIGEN; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ACYLATION; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CONTROLLED STUDY; GENOMICS; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR RECOGNITION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SPECIES INVASION; ADOLESCENT; BIOLOGY; BIOSYNTHESIS; BLOOD; CEREBROSPINAL FLUID; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; EPIDEMIC MENINGITIS; GENE EXPRESSION PROFILING; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MENINGOCOCCOSIS; METABOLISM; MICROBIOLOGY; MONOCYTE; NORWAY; PATHOGENICITY; PHOSPHORYLATION; SEPSIS; TUMOR CELL LINE; VIRULENCE;

ACYLATION; ADOLESCENT; ANTIGENS, BACTERIAL; CARRIER STATE; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MOLECULAR STRUCTURE; MONOCYTES; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP C; NORWAY; PHOSPHORYLATION; SEPSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 84966341067     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.666214     Document Type: Article

References (79)

1. John, C. M., Liu, M., and Jarvis, G. A. (2009) Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-α in human monocytes. J. Biol. Chem. 284, 21515-21525
2. Liu, M., John, CM., and Jarvis, G.A. (2010) Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways. J. Immunol. 185, 6974-6984
3. John, C. M., Liu, M., Phillips, N. J., Yang, Z., and Funk, C. R., Zimmerman, L. I., Griffiss, J. M., Stein, D.C., and Jarvis, G.A. (2012) Lack of lipidApyrophos-phorylation and of a functional lptA reduce inflammation by Neisseria commensals. Infect. Immun. 80, 4014-4026
4. Lappann, M., Danhof, S., Guenther, F., Olivares-Florez, S., Mordhorst, I. L., and Vogel, U. (2013) In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps. Mol. Microbiol. 89, 433-449
5. Takahashi, H., and Carlson, R. W., Muszynski, A., Choudhury, B., Kim, K. S., and Stephens, D. S., and Watanabe, H. (2008) Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells. Infect. Immun. 76, 5777-5789
6. Ram, S., and Cox, A. D., Wright, J. C, Vogel, U., Getzlaff, S., Boden, R., Li, J., and Plested, J. S., Meri, S., Gulati, S., Stein, D. C, Richards, J. C, Moxon, E. R., and Rice, P. A. (2003) Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. J. Biol. Chem. 278, 50853-50862
7. Lewis, L. A., Carter, M., and Ram, S. (2012) The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci. J. Immunol. 188, 5063-5072
8. Cheng, H., Yang, Z., Estabrook, M. M., and John, C. M., Jarvis, G. A., McLaughlin, S., and Griffiss, J. M. (2011) Human lipooligosaccharide IGG that prevents endemic meningococcal disease recognizes an internal lacto-N-neotetraose structure. J. Biol. Chem. 286, 43622-43633
9. Estabrook, M. M., and Jarvis, G. A., and McLeod Griffiss, J. (2007) Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis. Infect. Immun. 75, 1025-1033
10. John, C M., Liu, M., and Jarvis, G. A. (2009) Profiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine induction. J. Lipid Res. 50, 424-438
11. Stephenson, H. N, John, C. M., Naz, N, Gundogdu, O., Dorrell, N, and Wren, B. W., Jarvis, G. A., and Bajaj-Elliott, M. (2013) Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation. J. Biol. Chem. 288, 19661-19672
12. Bjune, G., Høiby, E. A., Grønnesby, J. K., Arnesen, O., Fredriksen, J. H., Halstensen, A., Holten, E., Lindbak, A. K., Nøkleby, H, Rosenqvist, E., Solberg, L. K., Closs, O., Eng, J., Frøholm, L. O., Lystad, A., et al. (1991) Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338, 1093-1096
13. Frøholm, L. O., Caugant, D. A., Holten, E., Høiby, E. A., Rosenqvist, E., and Wedege, E. (1991) Meningococcal strains isolated from teenage patients during the serogroup B vaccination trial in Norway: serotyping, serosubtyping, immunotyping and clonal analysis. NIPHAnn. 14, 139-143
14. Høiby, E. A., Bjune, G., Frøholm, L. O., Eng, J., Halstensen, A., Rosenqvist, E., Rønnild, E., and Wedege, E. (1991) The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis. NIPH Ann. 14, 107-121
15. Kahler, C. M., and Martin, L. E., Shih, G. C, Rahman, M. M., and Carlson, R. W., and Stephens, D. S. (1998) The (α2→8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect. Immun. 66, 5939-5947
16. Bergfeld, A. K., Claus, H., Lorenzen, N. K., Spielmann, F., Vogel, U., and Mühlenhoff, M. (2009) The polysialic acid-specific O-acetyltransferase O at C from Neisseria meningitidis serogroup C evolved apart from other bacterial sialate O-acetyltransferases. J. Biol. Chem. 284, 6-16
17. Bevanger, L., Bergh, K., Gisnås, G., Caugant, D. A., and Frøholm, L. O. (1998) Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods. J. Med. Microbiol. 47, 993-998
18. Conyn-van Spaendonck, M. A., Reintjes, R., Spanjaard, L., van Kregten, E., Kraaijeveld, A. G., and Jacobs, P. H. (1999) Meningococcal carriage in relation to an outbreak of invasive disease due to Neisseria meningitidis serogroup C in the Netherlands. J. Infect. 39, 42-48
19. Harrison, O. B., Claus, H., Jiang, Y., Bennett, J. S., and Bratcher, H. B., Jolley, K. A., Corton, C., Care, R., and Poolman, J. T., Zollinger, W. D., Frasch, C. E., and Stephens, D. S., Feavers, I., Frosch, M., Parkhill, J., et al. (2013) Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect. Dis. 19, 566-573
20. Tsai, C M., Mocca, L. F., and Frasch, C. E. (1987) Immunotype epitopes of Neisseria meningitidis lipooligosaccharide types 1 through 8. Infect. Immun. 55, 1652-1656
21. Kim, J. J., and Phillips, N. J., Gibson, B. W., Griffiss, J. M., and Yamasaki, R. (1994) Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes. Infect. Immun. 62, 1566-1575
22. Kahler, C. M., and Stephens, D. S. (1998) Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit. Rev. Microbiol. 24, 281-334
23. Tsai, CM., Chen, W. H., and Balakonis, P. A. (1998) Characterization of terminal NeuNAcα2-3Galβ1-4GlcNAc sequence in lipooligosaccharides of Neisseria meningitidis. Glycobiology 8, 359-365
24. Tsai, C. M., Kao, G., and Zhu, P. (2002) Influence of the length of the lipooligosaccharide α chain on its sialylation in Neisseria meningitidis. Infect. Immun. 70, 407-411
25. Kahler, C. M., Lyons-Schindler, S., Choudhury, B., Glushka, J., Carlson, R. W., and Stephens, D. S. (2006) O-Acetylation of the terminal N-acetylglucosamine of the lipooligosaccharide inner core in Neisseria meningitidis. Influence on inner core structure and assembly. J. Biol. Chem. 281, 19939-19948
26. Choudhury, B., and Kahler, C. M., Datta, A., Stephens, D. S., and Carlson, R. W. (2008) The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491. Carbohydr. Res. 343, 2971-2979
27. Liu, M., and John, C. M., and Jarvis, G. A. (2014) Induction of endotoxin tolerance by pathogenic Neisseria is correlated with the inflammatory potential of lipooligosaccharides and regulated by microRNA-146a. J. Immunol. 192, 1768-1777
28. Jolley, K. A., and Maiden, M. C. (2010) BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11, 595
29. Jones, J. W., and Shaffer, S. A., Ernst, R. K., Goodlett, D. R., and Turecek, F. (2008) Determination of pyrophosphorylated forms of lipid A in Gramnegative bacteria using a multivaried mass spectrometric approach. Proc. Natl. Acad. Sci. U.S.A. 105, 12742-12747
30. Kulshin, V. A., Zähringer, U., Lindner, B., and Frasch, C. E., Tsai, C. M., Dmitriev, B. A., and Rietschel, E. T. (1992) Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J. Bacteriol. 174, 1793-1800
31. van der Ley, P., Steeghs, L., and Hamstra, H. J., ten Hove, J., Zomer, B., and van Alphen, L. (2001) Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun. 69, 5981-5990
32. Wakarchuk, W. W., Gilbert, M., Martin, A., Wu, Y., and Brisson, J. R., Thibault, P., and Richards, J. C. (1998) Structure of an α-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1. Eur. J. Biochem. 254, 626-633
33. Tsai, C. M., Jankowska-Stephens, E., Mizanur, R. M., and Cipollo, J. F. (2009) The fine structure of Neisseria meningitidis lipooligosaccharide from the M986 strain and three of its variants. J. Biol. Chem. 284, 4616-4625
34. Cox, A. D., Li, J., and Richards, J. C. (2002) Identification and localization of glycine in the inner core lipopolysaccharide of Neisseria meningitidis. Eur. J. Biochem. 269, 4169-4175
35. Kahler, C. M., and Carlson, R. W., Rahman, M. M., Martin, L. E., and Stephens, D. S. (1996) Inner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the α1,2 N-acetylglucosamine transferase (RfaK). J. Bacteriol. 178, 1265-1273
36. Kahler, C. M., Datta, A., Tzeng, Y. L., and Carlson, R. W., and Stephens, D. S. (2005) Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes. Glycobiology 15, 409-419
37. Gu, X. X., and Tsai, C. M., and Karpas, A. B. (1992) Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis. J. Clin. Microbiol. 30, 2047-2053
38. Yamasaki, R., Nasholds, W., Schneider, H, and Apicella, M. A. (1991) Epitope expression and partial structural characterization of F62 lipooligosaccharide (LOS) of Neisseria gonorrhoeae: IgM monoclonal antibodies (3F11 and 1-1-M) recognize non-reducing termini of the LOS components. Mol. Immunol. 28, 1233-1242
39. Balthazar, J. T., Gusa, A., Martin, L. E., Choudhury, B., Carlson, R., and Shafer, W. M. (2011) Lipooligosaccharide structure is an important determinant in the resistance of Neisseria gonorrhoeae to antimicrobial agents of innate host defense. Front. Microbiol. 2, 30
40. Hobbs, M. M., and Anderson, J. E., Balthazar, J. T., Kandler, J. L., and Carlson, R. W., Ganguly, J., Begum, A. A., and Duncan, J. A., Lin, J. T., Sparling, P. F., and Jerse, A. E., and Shafer, W. M. (2013) Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men. MBio 4, e00892-00813
41. Lewis, L. A., and Shafer, W. M., Dutta Ray, T., Ram, S., and Rice, P. A. (2013) Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. Infect. Immun. 81, 33-42
42. Lewis, L. A., Choudhury, B., Balthazar, J. T., and Martin, L. E., Ram, S., Rice, P. A., and Stephens, D. S., Carlson, R., and Shafer, W. M. (2009) Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect. Immun. 77, 1112-1120
43. Quinn, E. M., Wang, J., and Redmond, H. P. (2012) The emerging role of microRNA in regulation of endotoxin tolerance. J. Leukocyte Biol. 91, 721-727
44. Saba, R., and Sorensen, D. L., and Booth, S. A. (2014) MicroRNA-146a: A dominant, negative regulator of the innate immune response. Front. Immunol. 5, 578
45. Wong, H. E., and Li, M. S., Kroll, J. S., Hibberd, M. L., and Langford, P. R. (2011) Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N lactamica. PLoS ONE 6, e26130
46. Steinshamn, S., and Waage, A. (2000) Lack of endotoxin tolerance with respect to TNFα production in the subarachnoid space. APMIS 108, 107-112
47. Brouwer, M. C, Spanjaard, L., and Prins, J. M., van der Ley, P., van de Beek, D., and van der Ende, A. (2011) Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide. J. Infect. 62, 479-483
48. Su, F., Brands, R., Wang, Z., Verdant, C, Bruhn, A., Cai, Y., Raaben, W., Wulferink, M., and Vincent, J. L. (2006) Beneficial effects of alkaline phosphatase in septic shock. Crit. Care Med. 34, 2182-2187
49. Koyama, I., Matsunaga, T., Harada, T., Hokari, S., and Komoda, T. (2002) Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 35, 455-461
50. Beumer, C, Wulferink, M., Raaben, W., Fiechter, D., Brands, R., and Seinen, W. (2003) Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J. Pharmacol. Exp. Ther. 307, 737-744
51. Pickkers, P., Heemskerk, S., Schouten, J., Laterre, P. F., and Vincent, J. L., Beishuizen, A., Jorens, P. G., Spapen, H., Bulitta, M., Peters, W. H., and van der Hoeven, J. G. (2012) Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit. Care 16, R14
52. Lu, M., and Munford, R. S. (2011) The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo. J. Immunol. 187, 3314-3320
53. Erwin, A. L., and Munford, R. S. (1990) Deacylation of structurally diverse lipopolysaccharides by human acyloxyacyl hydrolase. J. Biol. Chem. 265, 16444-16449
54. Munford, R. S., and Varley, A. W. (2006) Shield as signal: lipopolysaccharides and the evolution of immunity to Gram-negative bacteria. PLoS Pathog. 2, e67
55. Gioannini, T. L., Teghanemt, A., Zhang, D., Prohinar, P., and Levis, E. N., Munford, R. S., and Weiss, J. P. (2007) Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase. J. Biol. Chem. 282, 7877-7884
56. Shao, B., Lu, M., Katz, S. C., and Varley, A. W., Hardwick, J., Rogers, T. E., Ojogun, N., and Rockey, D. C., Dematteo, R. P., and Munford, R. S. (2007) A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J. Biol. Chem. 282, 13726-13735
57. Erwin, A. L., and Mandrell, R. E., and Munford, R. S. (1991) Enzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS. Infect. Immun. 59, 1881-1887
58. Lu, M., Zhang, M., Takashima, A., Weiss, J., and Apicella, M. A., Li, X. H., Yuan, D., and Munford, R. S. (2005) Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat. Immunol. 6, 989-994
59. Griffiss, J. M., and Jarvis, G. A., O'Brien, J. P., Eads, M. M., and Schneider, H. (1991) Lysis of Neisseria gonorrhoeae initiated by binding of normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strain-specific, properdin-binding-dependent alternative complement pathway activation. J. Immunol. 147, 298-305
60. Estabrook, M. M., and Griffiss, J. M., and Jarvis, G. A. (1997) Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect. Immun. 65, 4436-4444
61. Jarvis, G. A. (1994) Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae. Infect. Immun. 62, 1755-1760
62. Söderström, C., Braconier, J. H., Danielsson, D., and Sjöholm, A. G. (1987) Bactericidal activity for Neisseria meningitidis in properdin-deficient sera. J. Infect. Dis. 156, 107-112
63. Hellerud, B. C., Aase, A., Herstad, T. K., and Naess, L. M., Kristiansen, L. H., Trøseid, A. M., Harboe, M., Lappegård, K. T., Brandtzaeg, P., Høiby, E. A., and Mollnes, T. E. (2010) Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies. Infect. Immun. 78, 802-809
64. Stephens, D. S., Greenwood, B., and Brandtzaeg, P. (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 369, 2196-2210
65. Brandtzaeg, P., and van Deuren, M. (2012) Classification and pathogenesis of meningococcal infections. Methods Mol. Biol. 799, 21-35
66. Chang, Q., and Tzeng, Y. L., and Stephens, D.S. (2012) Meningococcal disease: changes in epidemiology and prevention. Clin. Epidemiol. 4, 237-245
67. van Deuren, M., Brandtzaeg, P., and van der Meer, J. W. (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13, 144-166
68. Farley, T. A., and Cohen, D. A., and Elkins, W. (2003) Asymptomatic sexually transmitted diseases: the case for screening. Prev. Med. 36, 502-509
69. Johnson, A. P. (1983) The pathogenic potential of commensal species of Neisseria. J. Clin. Pathol. 36, 213-223
70. Yazdankhah, S. P., and Caugant, D. A. (2004) Neisseria meningitidis: an overview of the carriage state. J. Med. Microbiol. 53, 821-832
71. Fransen, F., and Heckenberg, S. G., Hamstra, H. J., Feller, M., Boog, C. J., van Putten, J. P., van de Beek, D., van der Ende, A., and van der Ley, P. (2009) Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 5, e1000396
72. Persa, O. D., Jazmati, N., Robinson, N., Wolke, M., Kremer, K., Schweer, K., Plum, G., and Schlaak, M. (2014) A pregnant woman with chronic meningococcaemia from Neisseria meningitidis with lpxL1-mutations. Lancet 384, 1900
73. Rodenburg, G. D., Fransen, F., Bogaert, D., Schipper, K., and Groenwold, R. H., Hamstra, H.J., Westerhuis, B. M., van de Beek, D., van der Ley, P., Sanders, E. A., and van der Ende, A. (2012) Prevalence and clinical course in invasive infections with meningococcal endotoxin variants. PLoS ONE 7, e49295
74. Ladhani, S. N., Lucidarme, J., Newbold, L. S., and Gray, S. J., Carr, A. D., Findlow, J., Ramsay, M. E., and Kaczmarski, E. B., and Borrow, R. (2012) Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg. Infect. Dis. 18, 63-70
75. du Plessis, M., Wolter, N., Crowther-Gibson, P., Hamstra, H. J., Schipper, K., Moodley, C., Cohen, C., van de Beek, D., van der Ley, P., von Gottberg, A., and van der Ende, A. (2014) Meningococcal serogroup YlpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J. Infect. 68, 455-461
76. Estabrook, M. M., and Christopher, N. C., Griffiss, J. M., Baker, C. J., and Mandrell, R. E. (1992) Sialylation and human neutrophil killing of group C Neisseria meningitidis. J. Infect. Dis. 166, 1079-1088
77. Vogel, U., Hammerschmidt, S., and Frosch, M. (1996) Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med. Microbiol. Immunol. 185, 81-87
78. Gulati, S., Cox, A., Lewis, L. A., and Michael, F. S., Li, J., Boden, R., Ram, S., and Rice, P. A. (2005) Enhanced factor H binding to sialylated gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in gonococci. Infect. Immun. 73, 7390-7397
79. Vu, D. M., Shaughnessy, J., Lewis, L. A., Ram, S., and Rice, P. A., and Granoff, D. M. (2012) Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect. Immun. 80, 643-650